Kristie L. Kahl is vice president of content at MJH Life Sciences, overseeing CURE®, CancerNetwork®, the journal ONCOLOGY, Targeted Oncology, and Urology Times®. She has been with the company since November 2017.
In this episode of the “CURE Talks Cancer” podcast, we spoke with Matt Newman, who was diagnosed with brain cancer at 39, but refuses to let cancer define the legacy he has made.
After a car accident, and experiencing what he thought was a stroke, Matt Newman was diagnosed with brain cancer at the age of 39 — an experience he found strength and courage in.
With a wife and three children at home, as well as a cancer partner in his father-in-law facing his own pancreatic cancer diagnosis, Matt immediately went into fight mode. He utilized fitness and exercise to get through his craniotomy recovery, and went on to write “Starting At The Finish Line,” which tells his personal story.
“I’ve earned my legacy and cancer had nothing to do with it,” he says.
